1. Home
  2. VTRS vs SJM Comparison

VTRS vs SJM Comparison

Compare VTRS & SJM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • SJM
  • Stock Information
  • Founded
  • VTRS 1961
  • SJM 1897
  • Country
  • VTRS United States
  • SJM United States
  • Employees
  • VTRS N/A
  • SJM N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • SJM Packaged Foods
  • Sector
  • VTRS Health Care
  • SJM Consumer Staples
  • Exchange
  • VTRS Nasdaq
  • SJM Nasdaq
  • Market Cap
  • VTRS 11.1B
  • SJM 11.6B
  • IPO Year
  • VTRS N/A
  • SJM N/A
  • Fundamental
  • Price
  • VTRS $10.19
  • SJM $108.28
  • Analyst Decision
  • VTRS Hold
  • SJM Buy
  • Analyst Count
  • VTRS 5
  • SJM 12
  • Target Price
  • VTRS $10.40
  • SJM $117.82
  • AVG Volume (30 Days)
  • VTRS 11.7M
  • SJM 2.2M
  • Earning Date
  • VTRS 11-06-2025
  • SJM 08-27-2025
  • Dividend Yield
  • VTRS 4.71%
  • SJM 4.06%
  • EPS Growth
  • VTRS N/A
  • SJM N/A
  • EPS
  • VTRS N/A
  • SJM N/A
  • Revenue
  • VTRS $14,115,700,000.00
  • SJM $8,714,300,000.00
  • Revenue This Year
  • VTRS N/A
  • SJM $5.02
  • Revenue Next Year
  • VTRS $1.69
  • SJM $2.22
  • P/E Ratio
  • VTRS N/A
  • SJM N/A
  • Revenue Growth
  • VTRS N/A
  • SJM 2.54
  • 52 Week Low
  • VTRS $6.85
  • SJM $93.30
  • 52 Week High
  • VTRS $13.55
  • SJM $125.42
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 57.64
  • SJM 49.16
  • Support Level
  • VTRS $9.47
  • SJM $106.81
  • Resistance Level
  • VTRS $10.09
  • SJM $109.27
  • Average True Range (ATR)
  • VTRS 0.25
  • SJM 2.23
  • MACD
  • VTRS 0.04
  • SJM 0.08
  • Stochastic Oscillator
  • VTRS 80.21
  • SJM 68.30

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About SJM The J.M. Smucker Company

J.M. Smucker is a packaged food company that primarily sells through the US retail channel (73% of fiscal 2025 revenue came through its retail pet foods, coffee, and frozen handheld/spreads segments), with the remaining share consisting of sweet baked snacks (through the Hostess acquisition) and international (primarily Canada). Retail coffee is its largest category (32% of sales) with brands Folgers and Dunkin'. Pet foods (19% of sales) holds leading brands like Milk-Bone and Meow Mix. Of its remaining, approximately 22% comes from frozen handhelds and spreads, through brands Jif, Smucker's, and Uncrustables. The company acquired Hostess Brands in fiscal 2024 to boost its snack and convenience store presence.

Share on Social Networks: